Our Decipher team is looking forward to seeing you in San Fransisco.

Connect with us and learn more about our Decipher Prostate and Bladder Genomic Classifiers. 

We’re excited to showcase data on Decipher Prostate and Decipher GRID. 

See the schedule below for dates and times to view these presentations. 

Sunday, September 28, 2025

1:00 PM – 1:10 PM PT

• Late Breaking Podium Abstract # CT01: A Double-Blinded Placebo-Controlled Biomarker Stratified Randomized Trial of Apalutamide (APA) and Radiotherapy for Recurrent Prostate Cancer (NRG GU006, BALANCE trial) 

Presented by: Daniel Spratt, MD 

San Francisco Ballroom 

3:20 PM – 3:30 PM PT

• Podium Abstract # 139: Genomic and Transcriptomic Profiling of Radiation Resistant, Locally Recurrent Prostate Cancer 

Presented by: Beth Neilsen, MD, PhD 

Room 155/157 

Monday, September 29, 2025

5:00 PM – 6:00 PM PT

• Poster #3121: Evaluating the Correlation between Genomic Classifier and Digital Pathology-Based Multi-Modal AI Biomarkers in Localized Prostate Cancer

Presented by: Adeniyi Olabumuyi, MB, BS, MB, BS 

Hall F

Tuesday, September 30, 2025

12:45 PM – 2:00 PM PT

• Poster #3305: Assessing the Predictive Accuracy of Radiogenomic Models Incorporating the Decipher Genomic Classifier and Radiomic Features for Biochemical Recurrence in Prostate Cancer 

Presented by: Oluwaseyi Oderinde, PhD 

Hall F

5:20 PM – 5:25 PM PT

• Quick Pitch #1084: Prospective Phase II Trial of Short Course Androgen Deprivation, Pelvic SBRT, and Brachytherapy Boost for NCCN High-Risk Prostate Cancer with Low-Intermediate Risk Decipher Genomic Score

Presented by: Alexander Goglia, MD, PhD 

Room 156/158

Wednesday October 1, 2025

08:15 AM – 8:20 AM PT

• Podium #1116: Discordance of Adverse Molecular Features between the 22-Gene Genomic Classifier Score, Histologic Grade, and NCCN Risk Groups: Analysis of Over 200,000 Patients 

Presented by: Michael Zelefsky, MD, FASTRO

Room 155/157

10:40 AM – 10:50AM PT

• Podium #358: Validation of Six Androgen Production, Uptake and Conversion Genes (APUC-6) in the ECOG-ACRIN E3805 CHAARTED Prostate Cancer Trial

Presented by: Phuoc Tran, MD, PhD 

Room 154

10:50 AM – 11:00 AM PT

• Podium #359: Hallmark Interferon-Alpha Response Analysis in Localized Prostate Cancer: Analysis of the NRG Oncology/RTOG 9202, 9413, 9902, 0126, and 0521 Clinical Trials

Presented by: Adam Olson, MD, MS  

Room 154

11:00 AM – 11:10 AM PT

• Podium #360: Genomic Classifier and Multimodal AI Biomarker in Localized Prostate Cancer: Two Sides of the Same Coin

Presented by: Kosj Yamoah, MD, PhD

Room 154